Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety monitoring of clinical use of Compound Cortex Phellodendri Liquid Paint
ChiCTR2200066651Phase 4Completed
- Sponsor
- Beijing University of Chinese Medicine East Hospital
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of compound phellodendron liquid in open-ended topical indications, sponsored by Beijing University of Chinese Medicine East Hospital. Primary endpoint: Safety observation. Started Apr 2022; status: completed.
02
Drugs
compound phellodendron liquid
03
Conditions
open-ended topical indications
Beyond the preview
Go deeper on ChiCTR2200066651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066651.